Peds II (Pediatric Eplerenone Development Study II) - an open label, long-term study to evaluate the safety of eplerenone in the treatment of hypertension in children

Trial Profile

Peds II (Pediatric Eplerenone Development Study II) - an open label, long-term study to evaluate the safety of eplerenone in the treatment of hypertension in children

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Aug 2006

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Essential hypertension
  • Focus Adverse reactions
  • Acronyms PEDS-II
  • Most Recent Events

    • 29 Aug 2006 Status change
    • 30 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top